Enanta Pharmaceuticals (ENTA) Share-based Compensation (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Share-based Compensation of $3.7 million for Q1 2026, down 20.05% year-on-year from $4.7 million in Q1 2025, and down 1.63% on a QoQ basis from $3.8 million in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Share-based Compensation data on file, last reported at $3.7 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 20.05% year-over-year to $3.7 million; the trailing twelve-month figure through Mar 2026 stood at $15.8 million (down 32.87% YoY), and the FY2025 full-year result was $18.6 million, down 30.71% from the prior year.
- Share-based Compensation for Q1 2026 stood at $3.7 million, down from $3.8 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $8.1 million in Q4 2023 and bottomed at $3.7 million in Q1 2026.
- The 5-year median for Share-based Compensation is $6.5 million (2022), against an average of $6.0 million.
- The widest annual swing landed in 2022, when Share-based Compensation jumped 38.87%; it then tumbled 47.73% in 2025.
- A 5-year view of Share-based Compensation shows it stood at $7.1 million in 2022, then gained by 13.45% to $8.1 million in 2023, then tumbled by 30.04% to $5.7 million in 2024, then tumbled by 32.76% to $3.8 million in 2025, then decreased by 1.63% to $3.7 million in 2026.
- The last three Share-based Compensation figures came in at $3.7 million (Q1 2026), $3.8 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 3.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.75 Mn |
| Mar 31, 2026 | 3.75 Mn |
| Dec 31, 2025 | 3.81 Mn |
| Dec 31, 2025 | 3.81 Mn |
| Sep 30, 2025 | 4.03 Mn |
| Sep 30, 2025 | 4.03 Mn |
| Jun 30, 2025 | 4.18 Mn |
| Jun 30, 2025 | 4.18 Mn |
| Mar 31, 2025 | 4.69 Mn |
| Mar 31, 2025 | 4.69 Mn |
| Dec 31, 2024 | 5.67 Mn |
| Dec 31, 2024 | 5.67 Mn |
| Sep 30, 2024 | 7.72 Mn |
| Sep 30, 2024 | 7.72 Mn |
| Jun 30, 2024 | 5.42 Mn |
| Jun 30, 2024 | 5.42 Mn |
| Mar 31, 2024 | 5.56 Mn |
| Mar 31, 2024 | 5.56 Mn |
| Dec 31, 2023 | 8.10 Mn |
| Dec 31, 2023 | 8.10 Mn |
| Sep 30, 2023 | 6.72 Mn |
| Sep 30, 2023 | 6.72 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 7.36 Mn |
| Mar 31, 2023 | 7.36 Mn |
| Dec 31, 2022 | 7.14 Mn |
| Dec 31, 2022 | 7.14 Mn |
| Sep 30, 2022 | 6.83 Mn |
| Sep 30, 2022 | 6.83 Mn |
| Jun 30, 2022 | 7.60 Mn |
| Jun 30, 2022 | 7.60 Mn |
| Mar 31, 2022 | 6.47 Mn |
| Mar 31, 2022 | 6.47 Mn |
| Dec 31, 2021 | 6.06 Mn |
| Dec 31, 2021 | 6.06 Mn |
| Sep 30, 2021 | 5.35 Mn |
| Sep 30, 2021 | 5.35 Mn |
| Jun 30, 2021 | 5.48 Mn |
| Jun 30, 2021 | 5.48 Mn |
| Mar 31, 2021 | 5.28 Mn |
| Mar 31, 2021 | 5.28 Mn |
| Dec 31, 2020 | 4.88 Mn |
| Dec 31, 2020 | 4.88 Mn |
| Sep 30, 2020 | 4.75 Mn |
| Sep 30, 2020 | 4.75 Mn |
| Jun 30, 2020 | 4.76 Mn |
| Jun 30, 2020 | 4.76 Mn |
| Mar 31, 2020 | 4.98 Mn |
| Mar 31, 2020 | 4.98 Mn |
| Dec 31, 2019 | 5.10 Mn |
| Dec 31, 2019 | 5.10 Mn |
| Sep 30, 2019 | 4.51 Mn |
| Sep 30, 2019 | 4.51 Mn |
| Jun 30, 2019 | 4.16 Mn |
| Jun 30, 2019 | 4.16 Mn |
| Mar 31, 2019 | 4.71 Mn |
| Mar 31, 2019 | 4.71 Mn |
| Dec 31, 2018 | 5.84 Mn |
| Dec 31, 2018 | 5.84 Mn |
| Sep 30, 2018 | 4.11 Mn |
| Sep 30, 2018 | 4.11 Mn |
| Jun 30, 2018 | 4.03 Mn |
| Jun 30, 2018 | 4.03 Mn |
| Mar 31, 2018 | 3.59 Mn |
| Mar 31, 2018 | 3.59 Mn |
| Dec 31, 2017 | 4.12 Mn |
| Dec 31, 2017 | 4.12 Mn |
| Sep 30, 2017 | 3.21 Mn |
| Sep 30, 2017 | 3.21 Mn |
| Jun 30, 2017 | 3.10 Mn |
| Jun 30, 2017 | 3.10 Mn |
| Mar 31, 2017 | 3.49 Mn |
| Mar 31, 2017 | 3.49 Mn |
| Dec 31, 2016 | 3.27 Mn |
| Dec 31, 2016 | 3.27 Mn |
| Sep 30, 2016 | 2.51 Mn |
| Sep 30, 2016 | 2.51 Mn |
| Jun 30, 2016 | 2.47 Mn |
| Jun 30, 2016 | 2.47 Mn |
| Mar 31, 2016 | 2.38 Mn |
| Mar 31, 2016 | 2.38 Mn |
| Dec 31, 2015 | 1.99 Mn |
| Dec 31, 2015 | 1.99 Mn |
| Sep 30, 2015 | 1.80 Mn |
| Sep 30, 2015 | 1.80 Mn |
| Jun 30, 2015 | 1.58 Mn |
| Jun 30, 2015 | 1.58 Mn |
| Mar 31, 2015 | 1.43 Mn |
| Mar 31, 2015 | 1.43 Mn |
| Dec 31, 2014 | 1.03 Mn |
| Dec 31, 2014 | 1.03 Mn |
| Sep 30, 2014 | 795,000.00 |
| Sep 30, 2014 | 795,000.00 |
| Jun 30, 2014 | 776,000.00 |
| Jun 30, 2014 | 776,000.00 |
| Mar 31, 2014 | 752,000.00 |
| Mar 31, 2014 | 752,000.00 |
| Dec 31, 2013 | 359,000.00 |
| Dec 31, 2013 | 359,000.00 |
| Sep 30, 2013 | 286,000.00 |
| Sep 30, 2013 | 286,000.00 |
| Jun 30, 2013 | 239,000.00 |
| Jun 30, 2013 | 239,000.00 |
| Mar 31, 2013 | 257,000.00 |
| Mar 31, 2013 | 257,000.00 |
| Dec 31, 2012 | 281,000.00 |
| Dec 31, 2012 | 281,000.00 |
| Sep 30, 2012 | 243,000.00 |
| Sep 30, 2012 | 243,000.00 |
| Jun 30, 2012 | 95,000.00 |
| Jun 30, 2012 | 95,000.00 |
| Mar 31, 2012 | 31,000.00 |
| Mar 31, 2012 | 31,000.00 |